Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Stanford University
AstraZeneca
Fondazione del Piemonte per l'Oncologia
Mayo Clinic
Aminex Therapeutics, Inc.
Psyence Australia Pty Ltd
Eastern Cooperative Oncology Group
ViroMissile, Inc.
Hummingbird Bioscience
Bristol-Myers Squibb
Dana-Farber Cancer Institute
Washington University School of Medicine
University of Florida
Radiopharm Theranostics, Ltd
Tizona Therapeutics, Inc
Essen Biotech
Essen Biotech
Wake Forest University Health Sciences
St. Jude Children's Research Hospital
MacroGenics
Alliance for Clinical Trials in Oncology
Daiichi Sankyo
University of Nebraska
National Institutes of Health Clinical Center (CC)
NRG Oncology
Elephas
Innate Pharma
The Netherlands Cancer Institute
OncoNano Medicine, Inc.
Mayo Clinic
Memorial Sloan Kettering Cancer Center
Compass Therapeutics
M.D. Anderson Cancer Center
Strand Therapeutics Inc.
Institut Bergonié
Hadassah Medical Organization
Travera Inc
Memgen, Inc.
Institut Cancerologie de l'Ouest
University Health Network, Toronto
Shandong Boan Biotechnology Co., Ltd
UNICANCER
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Stanford University
BostonGene
University Health Network, Toronto
University Health Network, Toronto
Simcha IL-18, Inc.